Moderna, Inc. Annual Operating Income (Loss) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Moderna, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2023.
  • Moderna, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$70M, a 96.5% increase year-over-year.
  • Moderna, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$2.69B, a 1.05% decline year-over-year.
  • Moderna, Inc. annual Operating Income (Loss) for 2023 was -$4.24B, a 145% decline from 2022.
  • Moderna, Inc. annual Operating Income (Loss) for 2022 was $9.42B, a 29.2% decline from 2021.
  • Moderna, Inc. annual Operating Income (Loss) for 2021 was $13.3B.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$4.24B -$13.7B -145% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-23
2022 $9.42B -$3.88B -29.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-23
2021 $13.3B +$14.1B Jan 1, 2021 Dec 31, 2021 10-K 2024-02-23
2020 -$763M -$217M -39.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-24
2019 -$546M -$133M -32.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 -$413M -$144M -53.4% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 -$269M -$45.6M -20.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 -$224M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.